Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Insect Bite Related Symptoms

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

Insect bite related symptoms (pruritus and papules) are caused by the release of histamine by mast cells in the skin. Topical anti-histaminics can be used to promote relief of these symptoms. Dexchlorpheniramine maleate 1% cream is a topical anti-histaminic formulation approved by ANVISA in Brazil for the relief of skin irritation and allergies, including the ones caused by insect bites. The aim of the present study is to demonstrate non-inferiority of a new pharmacological preparation of dexchlorpheniramine maleate (1% lotion) with the standard preparation (1% cream) for the relief of insect bite related symptoms and to demonstrate the safety of both preparations.

Condition or disease	Intervention/treatment	Phase
Insect Bites	Drug: Dexchlorpheniramine 1% lotion; Drug: Dexchlorpheniramine 1% cream	Phase 3

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	30 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	None (Open Label)
Primary Purpose:	Treatment
Official Title:	Non-inferiority, Monocentric Comparative Open Study of Two Topical Pharmaceutical Preparations (Cream and Lotion) of Dexchlorpheniramine Maleate in the Evaluation of Safety and Efficacy for the Relief of Insect Bite Related-symptoms

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm	Intervention/treatment
Experimental: Dexchlorpheniramine 1% lotion	Drug: Dexchlorpheniramine 1% lotion; Small amount applied over the lesion twice a day for 7 days.
Active Comparator: Dexchlorpheniramine 1% cream	Drug: Dexchlorpheniramine 1% cream; Small amount applied over the lesion twice a day for 7 days.

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Pruritus intensity at insect bite site, evaluated with a 10 point Visual Analogic Scale (VAS) [ Time Frame: 7 days ]

Secondary Outcome Measures :

1. Composite clinical evaluation of erythema, pruritus and papule formation, performed by the investigator using a 4-point scale for each one of the parameters (absent, mild, moderate, intense). This evaluation constitutes the Insect Bite Score. [ Time Frame: 7 days ]

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	2 Years to 60 Years (Child, Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Presence of papules resulting from insect bites within the last 72 hours
• Presence of symmetric lesions to compare one side to the other
• Compliance of the subject to the treatment protocol
• Agreement with the terms of the informed consent by the participants or their legal guardians when younger than 18 years old

Exclusion Criteria:

• Pregnancy or risk of pregnancy
• Lactation
• Use of topical or systemic anti-inflammatory, anti-histaminics or immunosuppressive drugs within the last 48 hours prior to the study
• History of atopy or allergic diseases
• History of allergy of any component of the formulations
• Other conditions considered by the investigator as reasonable for non-eligibility

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Contacts

Contact: Sérgio Schalka, MD	+551136811334

Locations

Brazil
Medcin Instituto da Pele Ltda.	Not yet recruiting
Osasco, São Paulo, Brazil, 06023-000
Contact: Patricia C Pinto

Sponsors and Collaborators

Mantecorp Industria Quimica e Farmaceutica Ltd.

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	Celso Pereira Sustovich, Medical Director, Mantecorp Industria Quimica e Farmaceutica Ltda.
ClinicalTrials.gov Identifier:	NCT00995397 History of Changes
Other Study ID Numbers:	ERP 976-08
First Posted:	October 15, 2009
Last Update Posted:	October 22, 2009
Last Verified:	October 2009

Keywords provided by Mantecorp Industria Quimica e Farmaceutica Ltd.:

Insect bites; Dexchlorpheniramine; Lotion; Cream

Additional relevant MeSH terms:

Insect Bites and Stings; Bites and Stings; Poisoning; Chemically-Induced Disorders; Wounds and Injuries; Dexchlorpheniramine; Chlorpheniramine; Histamine H1 Antagonists	Histamine Antagonists; Histamine Agents; Neurotransmitter Agents; Molecular Mechanisms of Pharmacological Action; Physiological Effects of Drugs; Antipruritics; Dermatologic Agents; Anti-Allergic Agents